Kari Remes
Professor
Areas of expertise
Clinical haematology; Bone marrow transplantation
Clinical haematology; Bone marrow transplantation
Teaching
Hematologian luennointi ja seminaarit (C6 ja C11). Hematologian ryhmäopetus (C6). Hematologisten syventävien opinnäytteiden ohjaus.
Publications
- Mikä hoidoksi refraktaarissa AML:ssä?Cost analysis of a randomized stem cell mobilization study in multiple myeloma2017
- Duodecim
(Other publication) - Aikuisten akuutin myelooisen leukemian hoito2016
- DuodecimBlood
(A1 Refereed original research article in a scientific journal) - A Prospective Randomized Trial Comparing Cyclosporine/Methotrexate And Tacrolimus/Sirolimus As Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation (2016)
- HaematologicaDuodecim
(A1 Refereed original research article in a scientific journal) - A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma (2016)
- Bone Marrow Transplantation
(A1 Refereed original research article in a scientific journal) - Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison (2016)
- TransfusionBone Marrow Transplantation
(A1 Refereed original research article in a scientific journal) - (2016)
- Annals of Hematology
(A1 Refereed original research article in a scientific journal) - Prognostic Comparison Between ISS and R-ISS in Real-Life Setting of Myeloma Patients: An Example of Utilization of Electronic Biobank Database (2016)
(Other publication) - Trombosyyttisiirrot verenvuotojen ehkäisyssä (2016)
(A2 Refereed review article in a scientific journal ) - Application of sensitive alleleSEQR chimerism PCR from peripheral blood in allografted AML/MDS patients treated with pre-empitive post-transplant immunomudolation (2015)
- Leukemia
(B1 Non-refereed article in a scientific journal) - Autologous stem cell transplantation versus novel drugs or conventional chemothrerapy for patients with relapsed multiple myeloma after previous ASCT (2015)
(A1 Refereed original research article in a scientific journal)



